The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics

BACKGROUND: There is an urgent need for novel, noninvasive biomarkers to diagnose Alzheimer’s disease (AD) in the predementia stages and to predict the rate of decline. Therefore, we set up the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomarker Discovery (EMIF-AD MBD...

Descripción completa

Detalles Bibliográficos
Autores principales: Bos, Isabelle, Vos, Stephanie, Vandenberghe, Rik, Scheltens, Philip, Engelborghs, Sebastiaan, Frisoni, Giovanni, Molinuevo, José Luis, Wallin, Anders, Lleó, Alberto, Popp, Julius, Martinez-Lage, Pablo, Baird, Alison, Dobson, Richard, Legido-Quigley, Cristina, Sleegers, Kristel, Van Broeckhoven, Christine, Bertram, Lars, ten Kate, Mara, Barkhof, Frederik, Zetterberg, Henrik, Lovestone, Simon, Streffer, Johannes, Visser, Pieter Jelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035398/
https://www.ncbi.nlm.nih.gov/pubmed/29980228
http://dx.doi.org/10.1186/s13195-018-0396-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035398/
https://www.ncbi.nlm.nih.gov/pubmed/29980228
http://dx.doi.org/10.1186/s13195-018-0396-5

Ejemplares similares